Quantum Health Group Limited distributes medical imaging and patient treatment equipment and services in Australia, Thailand, Korea, the Philippines.
Price History & Performance
|Historical stock prices|
|Current Share Price||AU$0.07|
|52 Week High||AU$0.044|
|52 Week Low||AU$0.10|
|1 Month Change||14.75%|
|3 Month Change||16.67%|
|1 Year Change||37.26%|
|3 Year Change||218.18%|
|5 Year Change||250.00%|
|Change since IPO||-81.33%|
Recent News & Updates
Quantum Health Group (ASX:QTM) Has A Rock Solid Balance Sheet
Howard Marks put it nicely when he said that, rather than worrying about share price volatility, 'The possibility of...
Does Quantum Health Group (ASX:QTM) Deserve A Spot On Your Watchlist?
It's only natural that many investors, especially those who are new to the game, prefer to buy shares in 'sexy' stocks...
Quantum Health Group (ASX:QTM) Could Easily Take On More Debt
Legendary fund manager Li Lu (who Charlie Munger backed) once said, 'The biggest investment risk is not the volatility...
|QTM||AU Healthcare||AU Market|
Return vs Industry: QTM exceeded the Australian Healthcare industry which returned 11.5% over the past year.
Return vs Market: QTM exceeded the Australian Market which returned 20.2% over the past year.
Stable Share Price: QTM is not significantly more volatile than the rest of Australian stocks over the past 3 months, typically moving +/- 6% a week.
Volatility Over Time: QTM's weekly volatility (6%) has been stable over the past year.
About the Company
Quantum Health Group Limited distributes medical imaging and patient treatment equipment and services in Australia, Thailand, Korea, the Philippines. It operates through two segments, Medical and Environmental Services. The company distributes medical products in the field of radiology, oncology, aesthetics, and environmental health.
Quantum Health Group Fundamentals Summary
|QTM fundamental statistics|
Is QTM overvalued?See Fair Value and valuation analysis
Earnings & Revenue
|QTM income statement (TTM)|
|Cost of Revenue||AU$26.65m|
Last Reported Earnings
Jun 30, 2021
Next Earnings Date
|Earnings per share (EPS)||0.006|
|Net Profit Margin||12.27%|
How did QTM perform over the long term?See historical performance and comparison
Is Quantum Health Group undervalued compared to its fair value and its price relative to the market?
Undervalued compared to fair value
Share Price vs. Fair Value
Below Fair Value: QTM (A$0.07) is trading below our estimate of fair value (A$0.09)
Significantly Below Fair Value: QTM is trading below fair value by more than 20%.
Price To Earnings Ratio
PE vs Industry: QTM is good value based on its PE Ratio (11.6x) compared to the Australian Healthcare industry average (25.4x).
PE vs Market: QTM is good value based on its PE Ratio (11.6x) compared to the Australian market (19.8x).
Price to Earnings Growth Ratio
PEG Ratio: Insufficient data to calculate QTM's PEG Ratio to determine if it is good value.
Price to Book Ratio
PB vs Industry: QTM is good value based on its PB Ratio (1.9x) compared to the AU Healthcare industry average (2.1x).
How is Quantum Health Group forecast to perform in the next 1 to 3 years based on estimates from 0 analysts?
Forecasted Healthcare industry annual growth in earnings
In this section we usually present revenue and earnings growth projections based on the consensus estimates of professional analysts to help investors understand the company’s ability to generate profit. But as Quantum Health Group has not provided enough past data and has no analyst forecast, its future earnings cannot be reliably calculated by extrapolating past data or using analyst predictions.
This is quite a rare situation as 97% of companies covered by SimplyWall St do have past financial data.
How has Quantum Health Group performed over the past 5 years?
Historical annual earnings growth
Earnings and Revenue History
Quality Earnings: QTM has high quality earnings.
Growing Profit Margin: QTM's current net profit margins (12.3%) are higher than last year (9.2%).
Past Earnings Growth Analysis
Earnings Trend: QTM has become profitable over the past 5 years, growing earnings by 57.4% per year.
Accelerating Growth: QTM's earnings growth over the past year (25.2%) is below its 5-year average (57.4% per year).
Earnings vs Industry: QTM earnings growth over the past year (25.2%) underperformed the Healthcare industry 61.3%.
Return on Equity
High ROE: QTM's Return on Equity (16.3%) is considered low.
How is Quantum Health Group's financial position?
Financial Position Analysis
Short Term Liabilities: QTM's short term assets (A$40.6M) exceed its short term liabilities (A$26.2M).
Long Term Liabilities: QTM's short term assets (A$40.6M) exceed its long term liabilities (A$898.0K).
Debt to Equity History and Analysis
Debt Level: QTM's debt to equity ratio (15.5%) is considered satisfactory.
Reducing Debt: QTM's debt to equity ratio has reduced from 67.2% to 15.5% over the past 5 years.
Debt Coverage: QTM's debt is well covered by operating cash flow (95.6%).
Interest Coverage: QTM's interest payments on its debt are well covered by EBIT (13.9x coverage).
What is Quantum Health Group current dividend yield, its reliability and sustainability?
Dividend Yield vs Market
Notable Dividend: Unable to evaluate QTM's dividend yield against the bottom 25% of dividend payers, as the company has not reported any recent payouts.
High Dividend: Unable to evaluate QTM's dividend yield against the top 25% of dividend payers, as the company has not reported any recent payouts.
Stability and Growth of Payments
Stable Dividend: Insufficient data to determine if QTM's dividends per share have been stable in the past.
Growing Dividend: Insufficient data to determine if QTM's dividend payments have been increasing.
Current Payout to Shareholders
Dividend Coverage: Insufficient data to calculate payout ratio to determine if its dividend payments are covered by earnings.
Future Payout to Shareholders
Future Dividend Coverage: No need to calculate the sustainability of QTM's dividend in 3 years as they are not forecast to pay a notable one for the Australian market.
How experienced are the management team and are they aligned to shareholders interests?
Average board tenure
John Walstab (58 yo)
Mr. John Andrew Walstab has been Managing Director of Quantum Health Group Limited (formerly known as Quantum Energy Limited) since February 7, 2017 and serves as its Chief Executive Officer and Company Se...
CEO Compensation Analysis
Compensation vs Market: John's total compensation ($USD228.82K) is about average for companies of similar size in the Australian market ($USD302.45K).
Compensation vs Earnings: John's compensation has been consistent with company performance over the past year.
Experienced Board: QTM's board of directors are seasoned and experienced ( 11 years average tenure).
Who are the major shareholders and have insiders been buying or selling?
Insider Trading Volume
Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.
Recent Insider Transactions
Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.
Quantum Health Group Limited's employee growth, exchange listings and data sources
- Name: Quantum Health Group Limited
- Ticker: QTM
- Exchange: ASX
- Founded: 1975
- Industry: Health Care Distributors
- Sector: Healthcare
- Market Cap: AU$78.982m
- Shares outstanding: 1.13b
- Website: https://www.qhealthcare.com.au
Number of Employees
- Quantum Health Group Limited
- 22 Rosebery Avenue
- New South Wales
Company Analysis and Financial Data Status
|Data||Last Updated (UTC time)|
|Company Analysis||2021/10/16 07:04|
|End of Day Share Price||2021/10/15 00:00|
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.